7 results
P
mouse models of IBD
I/C
Trichinella infection or derived antigens, control group
O
disease activity index (DAI), myeloperoxidase (MPO) activity, macroscopic inflammation score, microscopic inflammation score, anti-inflammatory cytokines (IL-4, TGF-β, IL-10, IL-13), proinflammatory cytokines (IFN-γ, IL-6, TNF-α, IL-17), regulatory T (Treg) cells, M1 phenotypic macrophage marker (iNOS), M2 phenotypic macrophage marker (Arg-1)
P
advanced gallbladder cancer patients
I/C
palliative chemotherapy
O
survival, adverse effects
P
adult population, over 60 years old, under 18 years old
I/C
reminder sent by mail
O
adherence to influenza vaccination
P
gynecologic and breast cancer survivors
I/C
oncology health professionals initiating and conducting open, honest discussions around sexual concerns with patients, availability of information in multiple forms, appropriate timing of information provision according to women's preferences
O
factors that prevent and/or facilitate gynecologic and breast cancer patients with sexual concerns seeking and accessing sexual health-related services
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19